FrancophonIA/ELRC3.0 huggingface dataset:
English: It is not recommended to coadminister fosamprenavir and Nevirapine Teva if fosamprenavir is not co-administered with ritonavir (see section 4.4).
Croatian: Ne preporučuje se istodobna primjena fosamprenavira i Nevirapina Teva, ako se fosamprenavir ne primjenjuje u kombinaciji istodobno s ritonavirom (vidjeti dio 4.4).
English: However, patients should be advised that they may experience adverse reactions such as fatigue during treatment with Nevirapine Teva.
Croatian: Međutim, bolesnike treba upozoriti da tijekom liječenja Nevirapinom Teva mogu dobiti nuspojave, kao što je umor.
English: Nevirapine must be permanently discontinued in any patient experiencing hypersensitivity reaction (characterised by rash with constitutional symptoms, plus visceral involvement, such as hepatitis, eosinophilia, granulocytopenia, and renal dysfunction), see section 4.4.
Croatian: Primjena nevirapina se mora trajno prekinuti u svakog bolesnika kod kojeg se pojavi reakcija preosjetljivosti (karakterizirana osipom s općim simptomima, uz visceralne poremećaje, kao što su hepatitis, eozinofilija, granulocitopenija i disfunkcija bubrega),
English: Recommendations concerning co-administration
Croatian: Preporuke s obzirom na istodobnu primjenu
English: Nevirapine exhibited additive to synergistic anti-HIV-1 activity in combination with the protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, saquinavir and tipranavir, and the NRTIs abacavir, didanosine, emtricitabine, lamivudine, stavudine, tenofovir and zidovudine.
Croatian: amprenavirom, atazanavirom, indinavirom, lopinavirom, sakvinavirom i tipranavirom te s NRTI-ima, abakavirom, didanozinom, emtricitabinom, lamivudinom, stavudinom, tenofovirom i zidovudinom rezultiraju aditivnim do sinergističkom antivirusnom aktivnošću.
English: Didanosine 100-150 mg BID
Croatian: Didanozin 100-150 mg 2x/dan
English: For children under 16 years of age who weigh less than 50 kg or whose body surface area is below 1.25 m2 other nevirapine containing oral formulations are available and should be used if appropriate.
Croatian: Za bolesnike koji ne mogu progutati tabletu ili koji imaju tjelesnu masu manju od 50 kg ili čija je površina tijela ispod 1.25 m2 prema Mosteller formuli, trebali bi uzeti neke druge dostupne oralne oblike koji sadrže djelatnu tvar nevirapin.
English: Entecavir is not a substrate, inducer or an inhibitor of cytochrome P450 (CYP450) enzymes.
Croatian: Entekavir nije supstrat, induktor ili inhibitor enzima citokroma P450
English: The NEFA study is a controlled prospective randomised study which evaluated treatment options for patients who switch from protease inhibitor (PI) based regimen with undetectable load to either nevirapine, efavirenz or abacavir.
Croatian: NEFA je prospektivno, randomizirano kontrolirano ispitivanje koje je uspoređivalo opcije liječenja za bolesnike koji su s prethodnog liječenja inhibitorima proteaza prebačeni na nevirapin, efavirenz ili abakavir, a pri tome su imali nedetektabilno opterećenje virusa u plazmi.
English: - The other ingredients are microcrystalline cellulose, lactose monohydrate, povidone K25, sodium starch glycolate (Type A), colloidal silicon dioxide and magnesium stearate.
Croatian: Pomoćne tvari celuloza, mikrokristalična laktoza (u obliku hidrata) povidon K25 natrijev škroboglikolat (vrste A) silicijev dioksid, koloidni magnezijev stearat
English: ANTIFUNGALS
Croatian: ANTIFUNGICI
English: If it has been more than 8 hours since the dose was due only take the next dose at the usual time.
Croatian: Ako primijetite nakon više od 8 sati kad ste trebali uzeti dozu, uzmite sljedeću dozu u uobičajeno vrijeme.
English: Female gender and higher CD4 counts (>250/mm in adult females and >400/mm in adult males) at the initiation of nevirapine therapy are associated with a greater risk of hepatic adverse reactions if the patient has detectable plasma HIV-1 RNA - i.e. a concentration ≥ 50 copies/ml - at the initiation of nevirapine.
Croatian: 250/mm3 u odraslih žena i >400/mm3 u odraslih muškaraca) imaju na početku terapije nevirapinom i povišeni rizik jetrenih reakcija ako pri tome bolesnici imaju HIV-1 RNK u plazmi
English: ANTITHROMBOTICS
Croatian: ANTITROMBOTICI
English: Atazanavir/r Cmin ↓ 0.28 (0.20-0.40) Atazanavir/r Cmax ↓ 0.72 (0.60-0.86)
Croatian: Atazanavir/r AUC ↓ 0,58 (0,48-0,71) Atazanavir/r Cmin ↓ 0,28 (0,20-0,40) Atazanavir/r Cmax ↓ 0,72 (0,60-0,86)
English: Clarithromycin Cmin ↓ 0.44 (0.30Clarithromycin Cmax ↓ 0.77 (0.69
Croatian: Klaritromicin AUC ↓ 0,69 (0,62-0,76) Klaritromicin Cmin ↓ 0,44 (0,30-0,64) Klaritromicin Cmax ↓ 0,77 (0,69-0,86)
English: Rifabutin Cmin ↔ 1.07 (0.84-1.37) Rifabutin Cmax ↑ 1.28 (1.09-1.51)
Croatian: Rifabutin AUC ↑ 1,17 (0,98-1,40) Rifabutin Cmin ↔ 1,07 (0,84-1,37) Rifabutin Cmax ↑ 1,28 (1,09-1,51)
English: Ketoconazole 400 mg QD
Croatian: Ketokonazol 400 mg 1x/dan
English: Zidovudine AUC ↓ 0.72 (0.60-0.96)
Croatian: Zidovudin AUC ↓ 0,72 (0,60-0,96)
English: Very common (may affect more than 1 in 10 people): - rash
Croatian: Manje često (mogu se javiti do 1 od 100 osoba):
English: During HIV therapy there may be an increase in weight and in levels of blood lipids and glucose.
Croatian: Metabolički parametri Tijekom antiretrovirusne terapije mogu se povećati tjelesna težina i razine lipida i glukoze u krvi
English: If you develop severe liver, skin or hypersensitivity reactions whilst taking Nevirapine Teva, NEVER TAKE Nevirapine Teva again without referring to your doctor.
Croatian: Ako razvijete teške jetrene, kožne ili reakcije preosjetljivosti dok uzimate Nevirapin Teva,
English: Darunavir Cmin ↔ 1.02 (0.79-1.32) Darunavir Cmax ↑ 1.40 (1.14-1.73)
Croatian: Darunavir AUC ↑ 1,24 (0,97-1,57) Darunavir Cmin ↔ 1,02 (0,79-1,32) Darunavir Cmax ↑ 1,40 (1,14-1,73)
English: Rifampicin 600 mg QD
Croatian: Rifampicin 600 mg 1x/dan
English: Ritonavir Cmin ↔ 0.93 (0.76-1.14) Ritonavir Cmax ↔ 0.93 (0.78-1.07)
Croatian: Ritonavir AUC↔ 0,92 (0,79-1,07) Ritonavir Cmin ↔ 0,93 (0,76-1,14) Ritonavir Cmax ↔ 0,93 (0,78-1,07)
English: You should continue to take Nevirapine Teva for as long as instructed by your doctor.
Croatian: Nevirapine Teva potrebno je uzimati onoliko dugo koliko Vam je rekao liječnik.
English: EE AUC ↓ 0.80 (0.67 - 0.97)
Croatian: EE AUC ↓ 0,80 (0,67 - 0,97) EE Cmin NO
English: Methadone-maintained patients beginning Nevirapine Teva therapy should be monitored for evidence of withdrawal and methadone dose should be adjusted accordingly.
Croatian: Nevirapinom Teva treba pratiti radi znakova apstinencije te sukladno tome prilagoditi dozu metadona.
English: Efavirenz Cmin ↓ 0.68 (0.65-0.81) Efavirenz Cmax ↓ 0.88 (0.77-1.01)
Croatian: Efavirenz AUC ↓ 0,72 (0,66-0,86) Efavirenz Cmin ↓ 0,68 (0,65-0,81) Efavirenz Cmax ↓ 0,88 (0,77-1,01)
English: As hepatotoxicity is more frequent in women with CD4 cell counts above 250 cells/mm3 with detectable HIV-1 RNA in plasma (50 or more copies/ml),
Croatian: S obzirom da je hepatotoksičnost češća u žena s brojem CD4 stanica iznad 250 stanica/mm3 s detektabilnim HIV-1 RNK u plazmi (50 ili više kopija/mL), ova stanja moraju biti uzeta u obzir prilikom odluke o terapiji (vidjeti dio 4.4.).
English: or anaphylactic shock - decreased numbers of red blood cells (anaemia) - yellow skin (jaundice) - severe and life-threatening skin rashes (Stevens-Johnson syndrome/toxic epidermal necrolysis) - hives (urticaria) - fluid under the skin (angioedema) - joint pain (arthralgia) - muscle pain (myalgia) - decreased blood phosphorus - increased blood pressure
Croatian: - smanjenjenje broja crvenih krvnih stanica (anemija) - žuta koža (žutica) - teški i po život opasni osipi kože (Stevens-Johnsonov sindrom/toksična epidermalna nekroliza)
English: Amprenavir Cmin ↓ 0.65 (0.49-0.85) Amprenavir Cmax ↓ 0.75 (0.63-0.89)
Croatian: Amprenavir AUC ↓ 0,67 (0,55-0,80) Amprenavir Cmin ↓ 0,65 (0,49-0,85) Amprenavir Cmax ↓ 0,75 (0,63-0,89)
English: It is not recommended to coadminister ketoconazole and Nevirapine Teva (see section 4.4).
Croatian: Ne preporučuje se istodobna primjena ketokonazola i Nevirapina Teva (vidjeti dio 4.4.).
English: Itraconazole Cmin ↓ 0.13 Itraconazole Cmax ↓ 0.62
Croatian: Itrakonazol AUC ↓ 0,39 Itrakonazol Cmin ↓ 0,13
English: Read the package leaflet before use.
Croatian: NAČIN I PUT(EVI) PRIMJENE Prije uporabe pročitajte Uputu o lijeku.
English: In ACTG 245, a double-blind placebo controlled study, the frequency of serious medicinal product-related granulocytopenia was 5/305 (1.6 %).
Croatian: učestalost teške granulocitopenije povezane s lijekom bila je 5/305 (1,6%).
English: It is not recommended to coadminister boceprevir and Nevirapine Teva (see section 4.4).
Croatian: Ne preporučuje se istodobna primjena boceprevira i Nevirapina Teva (vidjeti dio 4.4).
English: TEVA UK Ltd Brampton Road, Hampden Park,
Croatian: TEVA UK Ltd Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG Velika Britanija
English: In a retrospective review of predominantly patients with a plasma HIV-1 viral load of 50 copies/ml or higher, women with CD4 counts > 250 cells/mm3 had a 12 fold higher risk of symptomatic hepatic adverse reactions compared to women with CD4 counts < 250 cells/mm3 (11.0 %
Croatian: U retrospektivnom pregledu uglavnom bolesnika s HIV-1 virusnim opterećenjem od 50 kopija/ml ili više u plazmi, žene s brojem CD4 >250 stanica/mm3
English: Each tablet contains 200 mg nevirapine (as nevirapine anhydrate).
Croatian: Svaka tableta sadrži 200 mg nevirapina (u bezvodnom obliku).
English: NET AUC ↓ 0.81 (0.70 - 0.93)
Croatian: NET AUC ↓ 0,81 (0,70 - 0,93) NET Cmin NO
English: NNRTIs Efavirenz 600 mg QD
Croatian: NNRTI-i Efavirenz 600 mg 1x/dan
English: Zidovudine Cmin ND Zidovudine Cmax ↓ 0.70 (0.49-1.04)
Croatian: 100-200 mg 3x/dan Zidovudin Cmin NO Zidovudin Cmax ↓ 0,70 (0,49-1,04)
English: In the case of concomitant antiviral therapy for hepatitis B or C, please refer also to the relevant product information for these medicinal products.
Croatian: U slučaju istodobne antivirusne terapije za hepatitis B ili C,
English: Nevirapine AUC ↑ 1.20
Croatian: Nevirapin AUC ↑ 1,26
English: In a mass balance/excretion study in eight healthy male volunteers dosed to steady state with nevirapine 200 mg given twice daily followed by a single 50 mg dose of 14C-nevirapine, approximately 91.4 ± 10.5 % of the radiolabelled dose was recovered, with urine (81.3 ± 11.1 %) representing the primary route of excretion compared to faeces (10.1 ± 1.5%).
Croatian: U studiji na osam zdravih muških dobrovoljaca koji su primali nevirapin 200 mg dvaput dnevno do stanja dinamičke ravnoteže, a zatim su primili jednokratnu dozu od 50 mg 14C-nevirapina, povrat radioaktivnosti iznosio je otprilike
English: Hepatic impairment
Croatian: - anafilaktičkog šoka
English: Adefovir did not influence any of the common CYP isoforms known to be involved in human drug metabolism and is excreted renally.
Croatian: CYP izoformi za koje se zna da su uključene u metabolizam lijeka u ljudi te se izlučuje renalnim putem.
English: Amprenavir Cmin ↓ 0.81 (0.69-0.96) Amprenavir Cmax ↔ 0.97 (0.85-1.10)
Croatian: Amprenavir AUC ↔ 0,89 (0,77-1,03) Amprenavir Cmin ↓ 0,81 (0,69-0,96) Amprenavir Cmax ↔ 0,97 (0,85-1,10)
English: Uncommon Stevens-Johnson syndrome/toxic epidermal necrolysis (which may be fatal)
Croatian: Manje često Stevens-Johnsonov sindrom/toksična epidermalna nekroliza (koji mogu biti fatalni) (0,2%), angioedem, urtikarija
English: Microcrystalline cellulose Lactose (as monohydrate) Povidone K25
Croatian: - Pomoćne tvari su mikrokristalična celuloza, laktoza ( u obliku hidrata), povidon
English: There is not enough evidence to substantiate that the absence of an increased risk for toxicity seen in pretreated women initiating nevirapine with an undetectable viral load (less than 50 copies/ml of HIV-1 in plasma) and CD4 cell counts above 250 cells/mm3 also applies to pregnant women.
Croatian: Nema dovoljno dokaza za zaključak da je odsutnost povećanog rizika toksičnosti viđen u prethodno liječenih žena na početku primjene nevirapina, s nedektabilnim virusnim opterećenjem (manje od 50 kopija
English: Rashes occur alone or in the context of drug reaction with eosinophilia and systemic symptoms, characterised by rash with constitutional symptoms such as fever, arthralgia, myalgia and lympadenopathy, plus visceral involvement, such as hepatitis, eosinophilia, granulocytopenia, and renal dysfunction.
Croatian: Osip se pojavljuje samostalno ili u sklopu reakcije na lijek uz eozinofiliju i sistemske simptome, poput, vrućice, artralgije, mijalgije i limpadenopatije, te visceralne poremećaje,
English: It is not recommended to coadminister atazanavir/ritonavir and Nevirapine Teva (see section
Croatian: Ne preporučuje se istodobna primjena atazanavir/ritonavira i Nevirapina Teva (vidjeti dio 4.4).
English: Very common rash (12.5 %)
Croatian: Poremećaji kože i potkožnog tkiva Vrlo često osip (12,5%)
English: Common (may affect up to 1 in 10 people): - decreased numbers of white blood cells (granulocytopenia) - allergic reactions (hypersensitivity) - headache - feeling sick (nausea) - vomiting - abdominal pain - loose stools (diarrhoea) - inflammation of the liver (hepatitis) - feeling tired (fatigue) - fever - abnormal liver function tests
Croatian: Često (mogu se javiti do 1 od 10 osoba): - smanjenje broja bijelih krvnih stanica (granulocitopenija) - alergijske reakcije (preosjetljivost) - glavobolja
English: Fluconazole 200 mg QD
Croatian: Flukonazol 200 mg 1x/dan
English: Lopinavir Cmin ↓ 0.45 (0.25-0.82) Lopinavir Cmax ↓ 0.86 (0.64-1.16)
Croatian: Lopinavir AUC ↓ 0,78 (0,56-1,09) Lopinavir Cmin ↓ 0,45 (0,25-0,82) Lopinavir Cmax ↓ 0,86 (0,64-1,16)
English: Sodium starch glycolate (Type A) Colloidal silicon dioxide Magnesium stearate
Croatian: K25, natrijev škroboglikolat (Vrste A), koloidni silicijev dioksid i magnezijev stearat.
English: Monotherapy with nevirapine has been associated with the development of NNRTI resistance.
Croatian: Teva je povezana s razvojem rezistencije na NNRTI.
English: If you experience severe rash or hypersensitivity (allergic reactions that may appear in the form of rash) accompanied by other side effects such as - fever, - blistering, - mouth sores, - inflammation of the eye, - swelling of the face, - general swelling, - shortness of breath, - muscle or joint pain, - general feelings of illness, - or abdominal pain
Croatian: Ako dobijete teški osip ili preosjetljivost (alergijske reakcije koje se mogu pojaviti u obliku osipa) popraćene drugim nuspojavama kao što su - vrućica, - pojava mjehurića,
English: Nevirapine Cmax ↑ 1.20
Croatian: Nevirapin AUC ↑ 1,20 Nevirapin Cmax ↑ 1,20
English: Nevirapine Cmin ↑ 1.34 (1.21-1.49) Nevirapine Cmax ↑ 1.25 (1.14-1.37)
Croatian: Nevirapin AUC ↑ 1,29 (1,19-1,40) Nevirapin Cmin ↑ 1,34 (1,21-1,49) Nevirapin Cmax ↑ 1,25 (1,14-1,37)
English: Rifampicin Cmin ND Rifampicin Cmax ↔ 1.06 (0.91-1.22)
Croatian: Rifampicin AUC ↔ 1,11 (0,96-1,28) Rifampicin Cmin NO Rifampicin Cmax ↔ 1,06 (0,91-1,22)
English: Nevirapine Cmin ↑ 1.47 (1.20-1.82) Nevirapine Cmax ↑ 1.18 (1.02-1.37)
Croatian: Nevirapin AUC ↑ 1,27 (1,12-1,44) Nevirapin Cmin ↑ 1,47 (1,20-1,82) Nevirapin Cmax ↑ 1,18 (1,02-1,37)
English: Lopinavir Cmin ↓ 0.54 (0.28-0.74) Lopinavir Cmax ↓ 0.81 (0.62-0.95)
Croatian: Lopinavir AUC ↓ 0,73 (0,53-0,98) Lopinavir Cmin ↓ 0,54 (0,28-0,74) Lopinavir Cmax ↓ 0,81 (0,62-0,95)
English: NRTIs
Croatian: NRTI-i
English: Musculoskeletal and connective tissue disorders Uncommon arthralgia, myalgia
Croatian: Manje često artralgija, mijalgija
English: Renal dysfunction: The single-dose pharmacokinetics of nevirapine has been compared in 23 patients with either mild (50 ≤ CLcr < 80 ml/min), moderate (30 ≤ CLcr < 50 ml/min) or severe renal dysfunction (CLcr < 30 ml/min), renal impairment or end-stage renal disease (ESRD) requiring dialysis, and 8 patients with normal renal function (CLcr > 80 ml/min).
Croatian: CLcr, >80 ml/min) (n=8), bolesnici s blagom (50≤ CLcr <80ml/min), umjerenom (30 ≤ CLcr
English: Nevirapine had a median EC50 value (50% inhibitory concentration) of 63 nM against a panel of group M HIV-1 isolates from clades A, B, C, D, F, G, and H, and circulating recombinant forms (CRF), CRF01_AE, CRF02_AG and CRF12_BF replicating in human embryonic kidney 293 cells.
Croatian: HIV-1 niza izolata skupine M podtipova A, B, C, D, F, G, i H te cirkulirajućih rekombinantnih oblika
English: Didanosine Cmin ND Didanosine Cmax ↔ 0.98 (0.79-1.21)
Croatian: Didanozin AUC ↔ 1,08 (0,92-1,27) Didanozin Cmin NO Didanozin Cmax ↔ 0,98 (0,79-1,21)
English: Ketoconazole Cmax ↓ 0.56 (0.42
Croatian: Itrakonazol Cmax ↓ 0,62
English: Herbal preparations containing St. John‘s Wort and Nevirapine Teva must not be co-administered (see section 4.3).
Croatian: Biljni pripravci koji sadrže gospinu travu i Nevirapin Teva ne smiju se primjenjivati istodobno (vidjeti dio
English: Hypersensitivity (anaphylactic reaction, angioedema and urticaria) have been reported.
Croatian: Prijavljeni su slučajevi preosjetljivosti (anafilaktička reakcija,
English: Saquinavir/ritonavir and Nevirapine Teva can be coadministered without dose adjustments.
Croatian: Fosamprenavir/ritonavir i Nevirapin Teva mogu se primjenjivati istodobno bez prilagodbe doze.
English: - abdominal pain
Croatian: - gubitak apetita
English: For patients who are unable to swallow tablets or who weigh less than 50 kg or whose body surface area is below 1.25 m2
Croatian: - čija je površina tijela veća od 1,25 kvadratnih metara Kod djece mlađe od 16 godina, tjelesne mase manje od 50 kg ili površine tijela manje od 1,25
English: (women more than 250 cells/mm³, men more than 400 cells/mm³) - pre-treated patients with detectable HIV-1 plasma viral load and higher CD4 cell counts at the start of nevirapine therapy (women more than 250 cells/mm³, men more than 400 cells/mm³)
Croatian: - osobe s poremećenim rezultatima testova jetrene funkcije - bolesnici prethodno neliječeni antiretrovirusnim lijekovima, s povišenim brojem CD4 stanica na početku terapije Nevirapinom Teva (žene s više od 250 stanica/mm3, muškarci s više od 400 stanica/mm3)
English: Rifabutin and Nevirapine Teva can be coadministered without dose adjustments.
Croatian: Rifabutin i Nevirapin Teva mogu se istodobno primjenjivati bez prilagodbe doze.
English: Tenofovir and Nevirapine Teva can be co-administered without dose adjustments.
Croatian: Tenofovir i Nevirapin Teva mogu se istodobno primjenjivati bez prilagodbe doze.
English: Nevirapine Teva and emtricitabine may be co-administered without dose adjustments.
Croatian: Nevirapin Teva i emtricitabin se mogu istodobno primjenjivati bez prilagodbe doze.
English: The opposite side is debossed with a scoreline.
Croatian: Na drugoj strani tablete nalazi se samo utisnuta razdjelna crta.
English: Raltegravir and Nevirapine Teva can be co-administered without dose adjustments.
Croatian: Raltegravir i Nevirapin Teva mogu se istodobno primjenjivati bez prilagodbe doze.
English: Fosamprenavir 1,400 mg BID
Croatian: Fosamprenavir 1400 mg 2x/dan,
English: Stavudine Cmin ND Stavudine Cmax ↔ 0.94 (0.86-1.03)
Croatian: Stavudin AUC ↔ 0,96 (0,89-1,03) Stavudin Cmin NO Stavudin Cmax ↔ 0,94 (0,86-1,03)
English: Telbivudine is not a substrate, inducer or inhibitor of the cytochrome P450 (CYP450) enzyme system.
Croatian: Telbivudin nije supstrat, induktor niti inhibitor enzimskog sustava citokroma
English: Methadone Cmin ND Methadone Cmax ↓ 0.58 (0.50 - 0.67)
Croatian: Metadon AUC ↓ 0,40 (0,31 - 0,51) Metadon Cmin NO Metadon Cmax ↓ 0,58 (0,50 - 0,67)
English: Nevirapine Cmin ↑ 1.22 (1.10-1.35) Nevirapine Cmax ↑ 1.13 (1.03-1.24)
Croatian: Nevirapin AUC ↑ 1,14 (1,05-1,24) Nevirapin Cmin ↑ 1,22 (1,10-1,35) Nevirapin Cmax ↑ 1,13 (1,03-1,24)
English: Nevirapine AUC ↑ 1.14 (1.05-1.24)
Croatian: Nevirapin Cmax ↑ 1,17 (1,09-1,25)
English: Name and address of the manufacturers responsible for batch release
Croatian: PROIZVOĐAČI ODGOVORNI ZA ZA PUŠTANJE SERIJE LIJEKA U PROMET Ime i adresa proizvođača odgovornih za puštanje serije lijeka u promet
English: The dose of Nevirapine Teva may need adjusting.
Croatian: Nakon prekida uzimanja gospine trave razine nevirapina mogu se povisiti pa može biti potrebna prilagodbe doze Nevirapina Teva.
English: Uncommon (may affect up to 1 in 100 people): - allergic reaction characterised by rash, swelling of the face, difficulty breathing (bronchial spasm)
Croatian: - alergijska reakcija koju karakteriziraju osip, oticanje lica, problemi pri disanju (bronhospazam)
English: Tipranavir and Nevirapine Teva can be co-administered without dose adjustments.
Croatian: Tipranavir i Nevirapin Teva mogu se istodobno primjenjivati bez prilagodbe doze.
English: Didanosine and Nevirapine Teva can be co-administered without dose adjustments.
Croatian: Didanozin i Nevirapin Teva mogu se istodobno primjenjivati bez prilagodbe doze.
English: anaphylactic reaction, angioedema, urticaria) Uncommon anaphylactic reaction Rare drug reaction with eosinophilia and systemic symptoms Nervous system disorders
Croatian: Rijetko reakcija na lijek uz eozinofiliju i sistemske simptome
English: Co-administration of Nevirapine Teva with elvitegravir in combination with cobicistat is not recommended (see section 4.4).
Croatian: Istodobna primjena Nevirapina Teva s elvitegravirom u kombinaciji s kobicistatom se ne preporučuje
English: If a hypersensitivity reaction occurs, characterised by rash with constitutional symptoms such as fever, arthralgia, myalgia and lymphadenopathy, plus visceral involvement, such as hepatitis, eosinophilia, granulocytopenia, and renal dysfunction, nevirapine must be permanently stopped and not be reintroduced (see section 4.3).
Croatian: Ako dođe do pojave reakcije preosjetljivosti, karakterizirane osipom s općim simptomima kao što su vrućica, artralgija, mijalgija i limfadenopatija, uz visceralne poremećaje, kao što su hepatitis,
English: Common headache
Croatian: - općeniti osjećaj bolesti
English: However, patients with ESRD requiring dialysis exhibited a 43.5 % reduction in nevirapine AUC over a one-week exposure period.
Croatian: Međutim, u bolesnika s terminalnom bubrežnom bolešću koja zahtijeva dijalizu tijekom jednotjednog ekspozicijskog razdoblja AUC
English: DMPA and Nevirapine Teva can be coadministered without dose adjustments.
Croatian: DMPA i Nevirapin Teva mogu se istodobno primjenjivati bez prilagodbe doze.
English: Nevirapine has been evaluated in both treatment-naïve and treatment-experienced patients.
Croatian: Nevirapin je ispitivan i u liječenju prethodno neliječenih bolesnika i u liječenju bolesnika prethodno liječenih drugim anti-HIV lijekovima.
English: Darunavir and Nevirapine Teva can be co-administered without dose adjustments.
Croatian: Darunavir i Nevirapin Teva mogu se istodobno primjenjivati bez prilagodbe doze.
English: Adefovir and Nevirapine Teva may be co-administered without dose adjustments.
Croatian: Adefovir i Nevirapin Teva se mogu istodobno primjenjivati bez prilagodbe doze.
English: Maraviroc and Nevirapine Teva can be co-administered without dose adjustments.
Croatian: Maravirok i Nevirapin Teva mogu se istodobno primjenjivati bez prilagodbe doze.
English: Cimetidine and Nevirapine Teva can be co-administered without dose adjustments.
Croatian: Cimetidin i Nevirapin Teva mogu se istodobno primjenjivati bez prilagodbe doze.
English: Lamivudine and Nevirapine Teva can be co-administered without dose adjustments.
Croatian: Lamivudin i Nevirapin Teva se mogu istodobno primjenjivati bez prilagodbe doze.
English: - muscle or joint pain - general feelings of illness - abdominal pain - hypersensitivity (allergic) reactions - inflammation of the liver (hepatitis) - if you have severe liver disease - if you have had to stop nevirapine treatment in the past because of changes in your liver function - if you are taking a medicine containing the herbal substance St John's Wort (Hypericum perforatum).
Croatian: - bol u trbuhu - reakcije preosjetljivosti (alergijske reakcije) - upala jetre (hepatitis) - ako imate tešku bolest jetre
English: Telbivudine and Nevirapine Teva may be co-administered without dose adjustments.
Croatian: Telbivudin i Nevirapin Teva se mogu istodobno primjenjivati bez prilagodbe doze.
English: Ribavirin and Nevirapine Teva may be co-administered without dose adjustments.
Croatian: Ribavirin i Nevirapin Teva se mogu istodobno primjenjivati bez prilagodbe doze.